Please enable Javascript to use all features and improve your user experience.
WCNR 2022
Programme
Posters
People
Search
EN
Posters on the topic "Spasticity"
Back
Attitudes and Practice Patterns of Canadian Physiatrists Surrounding Medical Cannabis
Karen Ethans (Winnipeg/ CA)
P 097
Which are the most frequently injected muscles in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in routine practice? Baseline data from the AboLiSh study
Jorge Jacinto (Estoril/ PT)
P 098
Immediate Effect Of Ultra Sound Guided Dry Needling in Spastic Soleus Muscle
Sanjivani Kamble (Pune/ IN)
P 099
Improved Disability and Quality of Life Outcomes in Hemiparetic Patients with Upper and Lower Limb Spasticity from Etiologies Other Than Stroke Treated with OnabotulinumtoxinA: Insights from the Adult Spasticity International Registry (ASPIRE) Study
Gerard E. Francisco (Houston, TX/ US)
P 100
Post Stroke Spasticity – An App for Self-Monitoring by Affected Patients
Friedemann Müller (Bad Aibling/ DE)
P 101
Feasibility data of different German questionnaires collecting information on comprehensibility and severity of three treatment-relevant symptoms of disabling spastic movement disorder after stroke
Klemens Fheodoroff (Hermagor/ AT)
Jörg Wissel (Berlin/ DE)
P 102
OnabotulinumtoxinA treatment and physician and patient satisfaction in patients with spastic hemiparesis from ASPIRE
Gerard E. Francisco (Houston, TX/ US)
P 103
Time duration to determine the optimal dose of botulinum toxin for the treatment of involuntary muscle hyperactivity in neurological disorders – Data analysis based on a botulinum toxin patient registry
Michaela M. Pinter (Krems/ AT; Horn/ AT)
P 104
Early, pro-active ,co-ordinated multidisciplinary management of severe spasticity in disorders of consciousness
Kudret Yelden (London/ GB)
Abigail Beddard (London/ GB)
P 105
Electrophysiological and Clinical Evaluation of the Effects of Anodal Transcutaneous Spinal Direct Current Stimulation (tsDCS) on Upper Extremity Spasticity in Chronic Stroke Patients: A Case Report
Hager Elserougy (6th of October/ EG)
P 106
Early detection of spasticity in acute post-stroke patients
Katharine A. Scarlat (Montreal/ CA)
P 107
Is dry needling safe in stroke patients: a scoping review?
Iris Malfait (Leuven/ BE)
P 108
Multi-modal therapy in post-stroke elbow flexor spasticity: utility of botulinum toxin (BoNT) and casting to help hemiparetic gait patterns
Rajiv Reebye (Vancouver/ CA)
P 109
Management of spasticity after stroke: Place of extracorporeal shock waves therapy (ESWT) in LMICs
Abderrazak Hajjioui (Fez/ MA)
P 110
Algo-dysfunctional syndrome in a patient with congenital spastic tetraparesis
Adriana Sarah Nica (Bucharest/ RO)
P 111
Familial spastic paraparesis in Strümpell-Lorrain
Asma Elhanafi (Marakesh/ MA)
P 114
Use of optokinetic chart stimulation based OKCSIB protocol to reduce upper limb spasticity and restore voluntary movements in chronic strokes and chronic traumatic brain injury: a retrospective case series.
Benjamin Chitambira (Ashford/ GB)
P 115
Effects of Anodal Transcutaneous Spinal Direct Current Stimulation (tsDCS) on Spasticity and Adaptive Plasticity in Traumatic Quadriparesis: A Case Report
Hager Elserougy (6th of October/ EG)
P 116
Role of diagnostic nerve block in evaluation and treatment of spastic equinovarus foot deformity
Prince Thakkar (Abu Dhabi/ AE)
P 117
Rotation of the spine reduces spasticity (Rota-Therapy)
Bettina Hutterer (Vorchdorf/ AT)
P 118
Multifocal Spasticity Treatment in Lower Limbs for People with Incomplete Spinal Cord Injury – A case series of bringing back old therapies
Karen Ethans (Winnipeg/ CA)
P 119
Botulin toxin type A in the management of lower-limb spasticity after traumatic spinal cord injury – Case series
Enola Maer (Cluj-Napoca/ RO)
P 120
Combination of Botulinum Toxin with Rehabilitation for Spasticity Management: A case series
Khalid El Youbi (Rabat/ MA)
P 121
Extracorporeal Shock Waves Therapy protocol in post-stroke triceps surae spasticity: A pilot randomised controlled trial
Carlotta Sola (Reggio Emilia/ IT)
P 122
Real-World Clinical Utilization Differences of OnabotulinumtoxinA and AbobotulinumtoxinA in Upper Limb Spasticity
Anand Patel (Rome/ IT)
P 123
Single centre, prospective, observational study methodology to assess the use of GripAble, a rehabilitation device, on patients with upper limb spasticity (ULS) receiving botulinum toxin A (BoNT-A)
Vadim Degtiar (Slough/ GB)
P 124
Design of a Global Inter-rater Reliability Study of the Post-stroke Spasticity Referral Tool
Jörg Wissel (Berlin/ DE)
Nabilah Alibhai (Marlow/ GB)
P 144
Management of spasticity and neuromuscular disorders in children with neuromuscular diseases
Khalid El Youbi (Rabat/ MA)
P 154
Management of hemifacial spasm by botulinum toxin in neurorehabilitation: Outcome and customer satisfaction
Abderrazak Hajjioui (Fez/ MA)
P 258
Tailoring interventions for meaningful client outcomes using a decision-making aid for upper limb neurorehabilitation: A multiple-case study series
Amelia Tan (Brisbane/ AU)
P 331
A Phase IV, Prospective, Observational, Multicenter Study Evaluating the Effectiveness and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity (PLLS)
Mark Gormley (St. Paul, MN/ US)
P 336
Comparison of the effects on passive muscle stiffness between botulinum toxin injection and combined therapy of toxin injection and short leg cast in the children with spastic cerebral palsy
Seung Ki Kim (Yongin-si/ KR; Seoul/ KR)
P 355
AbobotulinumtoxinA efficacy and safety in children with upper limb spasticity previously treated with botulinum toxin
Simon Page (Slough/ GB)
P 438
Case report and literature review of osmotic demyelination syndrome presenting with dysphagia
Hirotaka Matsuura (Inzai/ JP; Toyoake/ JP)
P 446
The Cenral Neural Effects of Motor Control Exercise on Patients with Non-specific Chronic Low Back Pain:A Resting-State Functional Magnetic Resonance Imaging Study
Chanjuan Zhang (Guangzhou/ CN)
P 451
Canadian physicians' practice patterns in the management of hemiplegic shoulder pain
Eve Boissonnault (Montreal/ CA)
P 496
Leg Activity Measure (LegA) sensitivity to change following treatment of lower limb spasticity with a single cycle of abobotulinumtoxinA in an ambulant population
Jorge Jacinto (Estoril/ PT)
P 530
The "PSS: early ID" application: Interactive features to engage providers in early identification and referral of patients with post-stroke spasticity
Jörg Wissel (Berlin/ DE)
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy